Agilon Health, Inc. (NYSE:AGL – Get Free Report) reached a new 52-week high during trading on Friday . The company traded as high as $98.60 and last traded at $98.1610, with a volume of 129893 shares trading hands. The stock had previously closed at $95.23.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on AGL. Jefferies Financial Group upgraded Agilon Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $27.50 to $48.00 in a research note on Thursday, May 7th. JPMorgan Chase & Co. downgraded shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price for the company. in a report on Monday, May 4th. Barclays raised shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price target on the stock in a research report on Tuesday, May 26th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $72.00 price objective (up from $37.50) on shares of Agilon Health in a research report on Friday, May 8th. Finally, Weiss Ratings cut shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 27th. Five investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $58.73.
View Our Latest Stock Analysis on AGL
Agilon Health Price Performance
Agilon Health (NYSE:AGL – Get Free Report) last issued its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. As a group, sell-side analysts anticipate that Agilon Health, Inc. will post -3.5 EPS for the current year.
Institutional Trading of Agilon Health
Institutional investors have recently modified their holdings of the business. AQR Capital Management LLC boosted its holdings in shares of Agilon Health by 243.3% in the first quarter. AQR Capital Management LLC now owns 501,440 shares of the company’s stock worth $2,171,000 after acquiring an additional 355,365 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Agilon Health by 3.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock worth $927,000 after purchasing an additional 7,209 shares during the period. Dynamic Technology Lab Private Ltd boosted its stake in Agilon Health by 28.4% in the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock worth $204,000 after purchasing an additional 10,424 shares during the period. Goldman Sachs Group Inc. grew its holdings in Agilon Health by 6.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company’s stock valued at $21,911,000 after buying an additional 311,158 shares in the last quarter. Finally, Creative Planning increased its position in shares of Agilon Health by 17.6% during the second quarter. Creative Planning now owns 170,969 shares of the company’s stock valued at $393,000 after buying an additional 25,548 shares during the period.
About Agilon Health
Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.
Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.
See Also
- Five stocks we like better than Agilon Health
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
